Existing preclinical CT platforms now can be retrofitted with a scaled-down SPECT system, announced Winnipeg, Manitoba, Canada, molecular imaging company Cubresa April 16.

An imaging system that fuses diffusion optical tomography (DOT) and computed tomography has been developed by scientists at Johns Hopkins University in Baltimore for Xstrahl, the company announced this month.

Mammography screening programs should be eradicated, all forms of mammography should be evaluated and clear, balanced information about the benefits and harms of screening should be disseminated to women, according to two members of the Swiss Medical Board in an editorial published by the New England Journal of Medicine on April 16. 

A molecular MRI system that scans at the nanoscale has been developed by a team of physicists at Harvard University, the institution announced yesterday.

Gamma Medica, makers of molecular breast imaging systems, announced April 17 that the company has created a strategic advisory board to counsel the Salem, N.H., based company’s operations.  

The genetic tests clinicians use to diagnose and stratify breast cancer are getting increasingly complex and studies show that there may be some discordance between generations when assessing a woman’s risk of cancer recurrence. Molecular subtyping may be the only way to gain clarity. 

Typical Alzheimer’s neuroimaging looks at amyloid deposition and neurofibrillary tangles, but a new quantitative method uses arterial input to bring signs of functional disease into sharper relief, according to a study published April 16 in the Journal of Nuclear Medicine.

The FDA is collaborating with a number of Alzheimer’s groups including the Alzheimer’s Association within the community to support the development of new biomarkers and improved diagnosis.